How ‘Pay to Delay’ Impacts Self-Insureds and Other Pharmaceutical Payers
Risk & Insurance - Sep 16, 2020
Two parallel courses of litigation, one in California and one in Illinois, have thrust the long-running dispute over the high cost of patented pharmaceuticals to the fore. Advertisement They have also reinforced how complex the issues are. Late in July, the U.S. Ninth Circuit Court upheld Califo...
Recommended Articles
Posted: Apr 16, 2026
A joint report from the Insurance Information Institute and Fenix24 found that insurers, despite set...
Posted: Apr 16, 2026
Jeff Green, the risk manager for Larimer County, Colo. Recounts his years in the profession and why...
Posted: Apr 15, 2026
Poor communication contributes to nearly 70% of workplace incidents, underscoring the business case...